Incyte (INCY) Gross Profit (2012 - 2026)
Incyte's Gross Profit was $1.57 billion in Q2 2026, up 38.0% from $1.14 billion a year earlier and up 34.3% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Gross Profit (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Incyte's Gross Profit was $5.39 billion through Jun 30, 2026, up 26.6% year-over-year; for FY2025, it came in at $4.77 billion, up 21.4% from FY2024.
- Gross Profit has now increased for 13 consecutive years, with a five-year compound annual growth rate of 13.5% (FY2020 to FY2025).
- In earlier years, Gross Profit was $3.93 billion in FY2024 (+14.2%), $3.44 billion in FY2023 (+7.9%), $3.19 billion in FY2022 (+12.4%) and $2.84 billion in FY2021 (+11.8%).
- The Q2 2026 figure marks the highest quarterly Gross Profit in data going back to Q1 2012.
- Compared with a year earlier, Gross Profit has increased for 15 straight quarters, with growth averaging 22.5% over the last eight quarters.
- The best year-over-year quarter for Gross Profit over five years was Q2 2026 (growth of 38.0%); the worst was Q3 2022 (a decline of 0.6%).
- Per Business Quant data, INCY's Gross Profit in the three quarters before Q2 2026 was $1.17 billion (Q1 2026), $1.39 billion (Q4 2025) and $1.27 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Incyte | 24.39 Bn | 9.33 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.57 Bn |
| Mar 31, 2026 | 1.17 Bn |
| Dec 31, 2025 | 1.39 Bn |
| Sep 30, 2025 | 1.27 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Mar 31, 2025 | 979.71 Mn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 967.13 Mn |
| Mar 31, 2024 | 819.93 Mn |
| Dec 31, 2023 | 943.59 Mn |
| Sep 30, 2023 | 858.93 Mn |
| Jun 30, 2023 | 886.28 Mn |
| Mar 31, 2023 | 751.85 Mn |
| Dec 31, 2022 | 867.54 Mn |
| Sep 30, 2022 | 768.72 Mn |
| Jun 30, 2022 | 860.76 Mn |
| Mar 31, 2022 | 690.62 Mn |
| Dec 31, 2021 | 818.98 Mn |
| Sep 30, 2021 | 773.12 Mn |
API Access
Incyte Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();